Filing Details
- Accession Number:
- 0001140361-15-007864
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2015-02-18 18:34:29
- Reporting Period:
- 2014-08-07
- Filing Date:
- 2015-02-18
- Accepted Time:
- 2015-02-18 18:34:29
- Original Submission Date:
- 2014-08-08
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
874716 | Idexx Laboratories Inc | IDXX | In Vitro & In Vivo Diagnostic Substances (2835) | 010393723 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1038684 | J Robert Murray | One Idexx Drive Westbrook ME 04092 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-08-07 | 500 | $127.28 | 3,500 | No | 4 | P | Indirect | by Spouse |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | by Spouse |
Footnotes
- The previously filed Form 4 inadvertently reported an incorrect share purchase price. This is the U.S. dollar equivalent of the corrected purchase price of 95.411 EUR per share using the EUR/USD currency exchange rate at the time of purchase (1 EUR = 1.3340 USD).